| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.480 | 18.670 | 17.746 | 10.698 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 18.480 | 18.670 | 17.746 | 10.698 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 20.008 | 20.698 | 21.553 | 12.764 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.527 | -2.028 | -3.807 | -2.066 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -2.082 | -2.401 | -3.997 | -2.183 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alflorexis Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 689 | 969 | 586 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 688 | 969 | 586 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -2.120 | -4.500 | -8.421 | -10.449 | -10.247 | -10.053 | -9.830 | -9.860 | -9.830 | -9.775 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 2.810 | 5.469 | 9.007 | 10.449 | 10.247 | 10.053 | 9.830 | 9.860 | 9.830 | 9.775 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Alflorexis Com S.r.l.